Mattson Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
5,144
+171
+3% +$36.8K 0.27% 101
2026
Q1
$1.08M Buy
4,973
+164
+3% +$36.4K 0.26% 109
2025
Q4
$1.1M Sell
4,809
-239
-5% -$54.4K 0.26% 103
2025
Q3
$1.17M Sell
5,048
-154
-3% -$31.4K 0.28% 98
2025
Q2
$966K Sell
5,202
-9
-0.2% -$1.67K 0.26% 106
2025
Q1
$1.09M Buy
5,211
+201
+4% +$39.1K 0.33% 90
2024
Q4
$989K Sell
5,010
-1,695
-25% -$312K 0.31% 99
2024
Q3
$1.15M Sell
6,705
-46
-0.7% -$8.59K 0.41% 94
2024
Q2
$1.16M Buy
+6,751
New +$1.12M 0.41% 94

Other funds holding ABBV

Mattson Financial Services's ABBV Position: Q2 2026 in Review

Mattson Financial Services increased its AbbVie (ABBV) stake by 3.4% in Q2 2026, buying an estimated $36.8K and bringing the position to 5,144 shares worth $1.31M. The position accounts for 0.27% of the portfolio, ranked #101.

Mattson Financial Services first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mattson Financial Services held 5,144 shares of AbbVie worth $1.31M as of Q2 2026.
  • Mattson Financial Services bought 171 AbbVie shares in Q2 2026, an estimated $36.8K.
  • AbbVie made up 0.27% of Mattson Financial Services's portfolio in Q2 2026, its #101 holding.
  • Mattson Financial Services first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mattson Financial Services's 13F filing for Q2 2026, filed 4 Aug 2026.